XRX Earnings

XRX reported its earnings on 2026-01-29, showcasing a revenue of 2.03B against an estimate of 2.08B, resulting in a -2.5% surprise. The EPS was -0.1, surpassing the expected 0.14 by -171.43%. The stock experienced a -12.45% price change on the earnings day and a -6.87% change over the next five days, reflecting market reactions to the results.

Following XRX's earnings announcement on 2026-01-29, the stock price moved by -12.45% on the day of the release. Over the subsequent five days, it saw a -6.87% change. Historically, XRX's stock price tends to shift by an average of 7.74% in the 10 days leading up to earnings and -0.24% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate XRX's annual revenue to reach 1.80B, while the EPS is projected at -0.04. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between XRX's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, XRX's stock price typically moves by 7.74% in the 10 days before its earnings and -0.24% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of -0.04 and revenue of 1.80B.

The earnings call highlights several negative aspects: a significant decline in revenue and free cash flow, lower operating margins, and increased losses per share. Although there are positive elements like acquisitions boosting certain segments, the Q&A reveals concerns about memory cost impacts and vague management responses on risk mitigation. The strategic guidance also reflects lower future expectations. Given these factors, the stock is likely to experience a negative reaction, particularly as a small-cap stock with a market cap of $1.5 billion.